Tinambacan, Baby Girl .

HRN: 22-28-53  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2022
AMPICILLIN 250MG (VIAL)
12/03/2022
12/10/2022
IV
60mg
Q12hours
PSNB Sec Non-institutional Delivery; RDS Sec Prematurity
Waiting Final Action 
12/03/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
12/03/2022
12/16/2022
IV
6mg
Q36hours
PSNB Sec To Non-institutional Delivery; RDS Sec To Prematurity
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: